Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of Skindex-16 construct validity in routinely collected psoriasis data: a retrospective analysis of the relationship between overall physician global assessment scores and Skindex-16 and measure discordance

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Patient-reported outcome measures (PROMs) capture disease severity metrics from the patient’s perspective, including health-related quality of life (HRQL). Disease-specific validation of PROMs improves their clinical utility. We evaluated construct validity (HRQL) for Skindex-16 in routinely seen psoriasis patients and characterized instances of discordance between Skindex-16 scores and clinician-reported outcome measure of disease severity. We retrospectively studied psoriasis patients seen by University of Utah Dermatology from 2016 to 2020. Cross-sectional construct validity was assessed using quantile regression and Spearman correlation between overall physician global assessment (OPGA) score and Skindex-16 scores. Longitudinal within-subject correlation was performed using linear mixed models. Discordance (10th percentile or lower OPGA and 90th percentile or higher Skindex-16 score [clear skin, poor HRQL; cspHRQL] or the reverse [severe skin, good HRQL; ssgHRQL]) was characterized descriptively. 681 first-visit patients with psoriasis were included. Median overall Skindex-16 score varied by ≥ 10 points across all levels of OPGA scores. OPGA and Skindex-16 domain scores were moderately correlated (emotions ρ = 0.54, functioning ρ = 0.47, and symptoms ρ = 53). Longitudinal correlations were similar (emotion ρxy = 0.54, functioning ρxy = 0.65, symptoms ρxy = 0.47). Visits with cspHRQL discordance occurred for each Skindex-16 domain (emotions = 7, functioning = 13, symptoms = 12). The ssgHRQL group was observed within the emotions (n = 1) and functioning (n = 23) domains. Median Skindex-16 scores are different between different levels of OPGA and show moderate cross-sectional and longitudinal correlation. This supports construct validity in patients with psoriasis. Severe discordance was rare and most often for those with clear skin but poor HRQL. These discordances can prompt further patient–clinician conversation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability statement

Datasets related to this article are available upon request.

References

  1. Greenhalgh J (2009) The applications of PROs in clinical practice: what are they, do they work, and why? Qual Life Res 18(1):115–123

    Article  PubMed  Google Scholar 

  2. Schäfer I, Hansen H, Schön G, Höfels S, Altiner A, Dahlhaus A et al (2012) The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the multicare cohort study. BMC Health Serv Res 12:89

    Article  PubMed  PubMed Central  Google Scholar 

  3. von dem Knesebeck O, Bickel H, Fuchs A, Gensichen J, Höfels S, Riedel-Heller SG et al (2015) Social inequalities in patient-reported outcomes among older multimorbid patients–results of the MultiCare cohort study. Int J Equity Health 7(14):17

    Article  Google Scholar 

  4. Kozlov N, Benzon HT (2020) Role of gender and race in patient-reported outcomes and satisfaction. Anesthesiol Clin 38(2):417–431

    Article  PubMed  Google Scholar 

  5. Carr E, Mahil SK, Brailean A, Dasandi T, Pink AE, Barker JN et al (2021) Association of patient mental health status with the level of agreement between patient and physician ratings of psoriasis severity. JAMA Dermatol 157(4):413–420

    Article  PubMed  Google Scholar 

  6. Barry MJ, Edgman-Levitan S (2012) Shared decision making–pinnacle of patient-centered care. N Engl J Med 366(9):780–781

    Article  CAS  PubMed  Google Scholar 

  7. Marshall S, Haywood K, Fitzpatrick R (2006) Impact of patient-reported outcome measures on routine practice: a structured review. J Eval Clin Pract 12(5):559–568

    Article  PubMed  Google Scholar 

  8. Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J et al (2017) Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst 109(9):djx029

    Article  Google Scholar 

  9. Taliercio VL, Snyder AM, Biggs AM, Kean J, Hess R, Duffin KC et al (2021) Clinicians’ perspectives on the integration of electronic patient-reported outcomes into dermatology clinics: a qualitative study. Qual Life Res 31:1719–1725

    Article  PubMed  Google Scholar 

  10. Pattinson RL, Trialonis-Suthakharan N, Gupta S, Henry AL, Lavallée JF, Otten M et al (2021) Patient-reported outcome measures in dermatology: a systematic review. Acta Derm Venereol 101(9):adv00559

    Article  PubMed  Google Scholar 

  11. Taliercio V, Langner AU, Secrest AM, Duffin KC (2022) Assessing psoriasis severity: Psychometric validation of overall physician global assessment. J Am Acad Dermatol 86(3):637–638

    Article  PubMed  Google Scholar 

  12. Feldman SR, Krueger GG (2005) Psoriasis assessment tools in clinical trials. Ann Rheum Dis 64(Suppl 2):ii65-68 (discussion ii69–73)

    PubMed  PubMed Central  Google Scholar 

  13. Rencz F, Gulácsi L, Péntek M, Poór AK, Sárdy M, Holló P et al (2018) Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis. Br J Dermatol 179(5):1102–1108

    Article  CAS  PubMed  Google Scholar 

  14. Rencz F, Gulácsi L, Péntek M, Szegedi A, Remenyik É, Bata-Csörgő Z et al (2020) DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea. Br J Dermatol 182(5):1167–1175

    Article  CAS  PubMed  Google Scholar 

  15. Barbieri JS, Gelfand JM (2021) Patient-reported outcome measures as complementary information to clinician-reported outcome measures in patients with psoriasis. JAMA Dermatol 157(10):1236

    Article  PubMed  PubMed Central  Google Scholar 

  16. Szabó Á, Brodszky V, Rencz F (2021) A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-relevant and Skindex-16. Br J Dermatol 24:bjd20765

    Google Scholar 

  17. Gergely LH, Gáspár K, Brodszky V, Kinyó Á, Szegedi A, Remenyik É et al (2020) Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol JEADV 34(11):2584–2592

    Article  CAS  PubMed  Google Scholar 

  18. Hornsey S, Stuart B, Muller I, Layton AM, Morrison L, King J et al (2021) Patient-reported outcome measures for acne: a mixed-methods validation study (acne PROMs). BMJ Open 11(3):e034047

    Article  PubMed  PubMed Central  Google Scholar 

  19. Paudyal P, Apfelbacher C, Jones C, Siddiqui S, El-Turki A, DeGiovanni C et al (2020) “DLQI seems to be ‘action’, and Skindex-29 seems to be ‘emotion’”: qualitative study of the perceptions of patients with psoriasis or eczema on two common dermatology-specific quality of life measures. Acta Derm Venereol 100(8):adv00105

    Article  PubMed  Google Scholar 

  20. Cappelleri JC, Zou KH, Bushmakin AG, Alvir JMJ, Alemayehu D, Symonds T (2014) Patient-reported outcomes: measurement, implementation and interpretation. CRC Press, Boca Raton, p 331 (Chapman & Hall/CRC biostatistics series)

    Google Scholar 

  21. Callis Duffin K, Gottlieb AB, Merola JF, Latella J, Garg A, Armstrong AW (2017) Defining outcome measures for psoriasis: the IDEOM report from the GRAPPA 2016 annual meeting. J Rheumatol 44(5):701–702

    Article  PubMed  Google Scholar 

  22. Chren MM, Lasek RJ, Sahay AP, Sands LP (2001) Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 5(2):105–110

    Article  CAS  PubMed  Google Scholar 

  23. Ringash J, O’Sullivan B, Bezjak A, Redelmeier DA (2007) Interpreting clinically significant changes in patient-reported outcomes. Cancer 110(1):196–202

    Article  PubMed  Google Scholar 

  24. Fernandez-Peñas P, Jones-Caballero M, Espallardo O, García-Díez A (2012) Comparison of Skindex-29, Dermatology Life Quality Index, psoriasis disability index and medical outcome study short form 36 in patients with mild to severe psoriasis: quality of life in psoriasis. Br J Dermatol 166(4):884–887

    Article  PubMed  Google Scholar 

  25. Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42

    Article  PubMed  Google Scholar 

  26. Hamlett A, Ryan L, Serrano-Trespalacios P, Wolfinger R (2003) Mixed models for assessing correlation in the presence of replication. J Air Waste Manag Assoc 53(4):442–450

    Article  CAS  PubMed  Google Scholar 

  27. Shan G, Zhang H, Jiang T (2020) Correlation coefficients for a study with repeated measures. Comput Math Methods Med 2020:7398324

    Article  PubMed  PubMed Central  Google Scholar 

  28. King MT (2011) A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 11(2):171–184

    Article  PubMed  Google Scholar 

  29. Fortune DG, Richards HL, Griffiths CEM, Main CJ (2002) Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 41(Pt 2):157–174

    Article  PubMed  Google Scholar 

  30. Fortune DG, Richards HL, Main CJ, Griffiths CEM (2000) Pathological worrying, illness perceptions and disease severity in patients with psoriasis. Br J Health Psychol 5(1):71–82

    Article  Google Scholar 

  31. Fortune DG, Richards HL, Kirby B, McElhone K, Main CJ, Griffiths CEM (2004) Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients’ well-being. Br J Dermatol 151(6):1219–1226

    Article  CAS  PubMed  Google Scholar 

  32. Szabó Á, Brodszky V, Rencz F (2021) A comparative study on the measurement properties of DLQI, DLQI‐R and Skindex‐16. Br J Dermatol b20765

  33. Schmitt-Egenolf M (2016) Physical activity and lifestyle improvement in the management of psoriasis. Br J Dermatol 175(3):452–453

    Article  CAS  PubMed  Google Scholar 

  34. Russo PAJ, Ilchef R, Cooper AJ (2004) Psychiatric morbidity in psoriasis: a review. Australas J Dermatol 45(3):155–159 (quiz 160–1)

    Article  PubMed  Google Scholar 

  35. Henry AL, Chisholm A, Carter LA, Bundy C, Griffiths CEM, Kyle SD (2020) The relationship between sleep disturbance, symptoms and daytime functioning in psoriasis: a prospective study integrating actigraphy and experience sampling methodology. Sleep Med 72:144–149

    Article  PubMed  Google Scholar 

  36. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol Off J Am Soc Clin Oncol 34(6):557–565

    Article  CAS  Google Scholar 

  37. Mierzynska J, Piccinin C, Pe M, Martinelli F, Gotay C, Coens C et al (2019) Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review. Lancet Oncol 20(12):e685–e698

    Article  PubMed  Google Scholar 

  38. Secrest AM, Chren MM, Hopkins ZH, Chen SC, Ferris LK, Hess R (2019) Benefits of electronically capturing patient-reported outcomes in dermatology for patient care. Br J Dermatol 181:826–827

    Article  CAS  PubMed  Google Scholar 

  39. Secrest AM, Hopkins ZH, Frost ZE, Taliercio VL, Edwards LD, Biber JE et al (2020) Quality of life assessed using Skindex-16 scores among patients with acne receiving isotretinoin treatment. JAMA Dermatol 156:1098

    Article  PubMed  Google Scholar 

  40. Joseph A, Prasad S, Hynan LS, Chren MM, Chong B (2021) Differences in quality of life in patients with cutaneous lupus erythematosus with varying income levels. Lupus 30(6):972–980

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Author notes

  1. Z. H. Hopkins and G. Kuceki have contributed equally to this manuscript.

Authors and Affiliations

  1. Department of Dermatology, University of Utah, 30 N 1900 East, 4A330, Salt Lake City, UT, 84132, USA

    Z. H. Hopkins, G. Kuceki, V. L. Taliercio, A. M. Snyder, K. C. Duffin & A. M. Secrest

  2. Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA

    A. M. Snyder, R. Hess & A. M. Secrest

  3. Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA

    G. J. Stoddard & R. Hess

Authors
  1. Z. H. Hopkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Kuceki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. L. Taliercio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. M. Snyder
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. J. Stoddard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. C. Duffin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. M. Secrest
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AMS, VT, AS, KD, RH: Conceptualization VT, ZHH, GS, AS: Methodology, Software VT, ZH, AMS: Data curation GK, VT, AS, ZHH, AMS: Writing- Original draft preparation, Visualization AMS, KD, RH: Supervision GK, ZHH, VT, AS, GS, KD, RH, AMS: Writing- Reviewing and Editing,

Corresponding author

Correspondence to A. M. Secrest.

Ethics declarations

Conflict of interest

Authors ZH Hopkins, G Kuceki, AM Snyder, VL Taliercio, GJ Stoddard, KC Duffin, R Hess have no relevant conflicts of interest to disclose. AM Secrest has received support from a Public Health Career Development Award from the Dermatology Foundation.

IRB

This study was approved by the University of Utah Institutional Review Board (#76927).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hopkins, Z.H., Kuceki, G., Taliercio, V.L. et al. Evaluation of Skindex-16 construct validity in routinely collected psoriasis data: a retrospective analysis of the relationship between overall physician global assessment scores and Skindex-16 and measure discordance. Arch Dermatol Res 315, 1151–1159 (2023). https://doi.org/10.1007/s00403-022-02491-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-022-02491-4

Keywords

Search

Navigation